Good MorningEquity markets closed out the first half of the year with a whimper. The S&P 500 gained less than 0.25% at the height of the session but did manage to set a new all-time high. The index gained a little bit more than 8% over the last three months and looks poised to set new highs again in the coming quarter. The risk for the market now is momentum. The MACD momentum indicator is diverging from the new high and suggests underlying weakness within the market. Without some new Catalyst to drive sentiment the risk of a market correction grows daily.
The next possible catalyst is Friday's NFP report. The June read of the ADP report suggests strong job creations in June if less than the expected 1 million new jobs. If the non-farm payrolls report echoes the sentiment the market will most likely move higher.
Featured: Everyone’s watching Nvidia right now. Here’s why I’m excited. (Ad) 
|
Markets | | |
Let's skip the lengthy intro. The easiest way to lose money in the stock market: Timing the market.
Most day traders don't want to hear it. They plug their ears and continue to trade anyway. I know a day trader whose losses continue to mount but he keeps doing it anyway because well, he's addicte... Read the Full Story |
|
|
Tech | | | Wall Street closed out its fifth straight quarterly gain Wednesday, continuing its comeback from a steep drop in early 2020 at the onset of the coronavirus pandemic.
The S&P 500 edged up 0.1%, bringing its advance over the past three months to 8.2% and 14.4% for the first half of... Read the Full Story |
|
Stocks | | | There are always certain seasonal trends that impact markets throughout the year, and that is certainly the case during the summer months. Although the market tends to see less volume during this time period, there are still plenty of great buying opportunities that can reward investors who are cogn... Read the Full Story |
|
From Our PartnersAs you may have seen over the last few weeks, I've been giving out special daily setups on my favorite ticker.
We’ve been taking these setups @ 10AM and so far, we've posted 28 different payouts …
Each of which were delivered at exactly 4PM as the market closed.
You see, these setups require zero oversight and have shown the power to deliver in the most chaotic market conditions.
And after a few weeks of fine-tuning … I knew it was time to let you in on The 4 PM Payout Plan.
That's why Jack Carter and I pulled back the curtain to reveal how we've been able to nail in a 96% win rate in the same window the market lost 11 trillion dollars in value. | | | We also revealed how you can find and execute these setups on your own without any help at all. |
|
Markets | | | Nvdia (NASDAQ: NVDA), 360 DigiTech (NASDAQ: QFIN) and Endava (NYSE: DAVA) are making investors the old-fashioned way: By earning institutional support. All three stocks are moving higher on rising fund ownership. Read the Full Story |
|
Markets | | | Social media 3D gaming platform provider Roblox (NYSE: RBLX) stock has been a rollercoaster in 2021 climbing from a low of $60.50 in March to reaching highs of $103.87 in June 2021. Shares of the leading mobile gaming publisher in the U.S. are attempting a recovery off $78.56 recent lows. The Compan... Read the Full Story |
|
From Our Partners2025 is off to a turbulent start—markets are swinging wildly, inflation pressures remain high, and recession fears are creeping back into headlines.
But even in uncertain times, innovation doesn’t slow down.
In fact, artificial intelligence (AI) is accelerating faster than ever—creating new profit opportunities while the broader market struggles.
Our latest research reveals two AI stocks trading under $15 that could thrive even as volatility grows. These under-the-radar companies are positioned to ride the next wave of AI-driven demand—and they’re still flying below most investors’ radar. | | | 👉[Click here to access your FREE AI stocks report now.] |
|
Tech | | | Didi Global Inc., a Chinese ride-hailing service, gained 1% Wednesday in its highly anticipated U.S. stock market debut, giving up most of a early double-digit gain.
The Beijing-headquartered company's initial public offering of 288 million shares was priced at $14 a share and opened ... Read the Full Story |
|
Politics | | | The pandemic has brought one good thing to western Albania's Divjaka-Karavasta Lagoon — badly needed peace and quiet for endangered mating pelicans, and resulting population growth.
Regional environmental officials say nesting pairs have increased by one-fifth in the last two years, f... Read the Full Story |
|
Politics | | | JAKARTA, Indonesia — Authorities in the Indonesian city of Bekasi on the outskirts of Jakarta are holding a mass coronavirus vaccination for 25,000 people at the city’s main stadium Thursday.
Officials say more than 1,500 health care workers, including 550 giving shots, are involved i... Read the Full Story |
|
Politics | | | Donald Trump’s company and his longtime finance chief have been indicted on charges stemming from a New York investigation into the former president’s business dealings, a person familiar with the matter told The Associated Press.
The charges against the Trump Organization and the com... Read the Full Story |
|
Markets | | | Supply chain management solutions provider American Software (NASDAQ: AMSWA) stock is finally breaking as metrics improve. The supply chain management software provider has been a relative under-the-radar stock that has stayed under the $20 range for the majority of over a decade. The Company has be... Read the Full Story |
|
The Early Bird Stock Of The Day Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases worldwide. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, vaccines, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, and oligonucleotide building blocks, as well as custom enzyme development and manufacturing and CleanCap capping technology. The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody, and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, viral clearance prediction kits, and custom services. The company serves biopharmaceutical companies, and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. The company was incorporated in 2020 and is headquartered in San Diego, California. | | View Today's Stock Pick |
|
